This site is intended for UK healthcare professionals

 

Featured Videos

In this masterclass, Alison Pottle and Jai Cegla provide discuss screening for familial hypercholesterolaemia (FH), treatment advances in dyslipidaemia, the role of lipid apheresis in specific populations and the importance of patient education.
Professor Paul Kalra summarises key findings presented at the 2024 Heart Failure Association ESC meeting in Lisbon. He discusses the new data on hypertrophic cardiomyopathy, heart failure with reduced ejection fraction, and challenges in diagnosis and treatment optimisation. He also explores the early benefits of sodium-glucose co-transporter 2 inhibitors and evidence-based treatments for heart failure with preserved ejection fraction.
Many of us understand the importance of exercise to improve not only our cardiovascular health, but health in general. Despite healthier living, cardiac-related injury or even death can occur in those who appear physically healthy, even athletes. Join Dr Gherardo Finocchiaro as he discusses the aetiology and epidemiology of sudden cardiac death, and the importance of cardiac screening, diagnosis and risk minimisation.
Join Professor John McMurray as he highlights some of the must-see sessions at the upcoming ESC Congress 2024 in London. Do not miss out on this unique opportunity to advance your knowledge and network with leading experts in cardiology.
Watch Terry McCormack and Peter Green discuss the national guidelines for primary and secondary prevention of cardiovascular disease (CVD), risk assessment and recommended lipid targets for CVD, and the availability of smart open-access data tools that can reduce health inequalities and improve treatment outcomes for your patients.
COVID-19, and specifically long COVID, is associated with an increased risk of cardiovascular disease. Listen as Professor Banerjee describes his work in this area, especially the STIMULATE-ICP trial, which looks at long COVID’s physiological and social impact. Find out about what the NHS is doing to tackle COVID-19 and its associated cardiovascular and metabolic abnormalities.
Heart failure prevalence is increasing in the UK, requiring long-term strategies. Join Lisa Anderson and Janine Hogan from the British Society for Heart Failure to see how a new initiative – 25in25 – aims to tackle this challenge.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.